Ligand Pharmaceuticals Inc (LGND)

Financing Cash Flow

$950.28M

TTM · Period ending: · USD

LGND logo

LGND Financing Cash Flow

Latest reported$950.28M
LGND TTM Cash from Financing ($19.20M → $950.28M)
High-resolution chart · PNG

LGND financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
950,276,000
418,839,000
428,296,000
440,354,000
85,789,000
80,283,000
97,182,000
83,058,000
31,248,000
-46,000,000
-58,998,000
-70,560,000
-114,659,000
-106,344,000
-275,990,000
-266,528,001
-226,084,001
-216,547,001
-137,761,001
-169,454,000
-172,775,000
-122,875,000
-310,545,000
-366,709,000
-574,315,000
-611,901,000
-485,172,000
-748,564,000
-478,335,000
172,785,000
328,585,000
668,415,000
610,902,000
-2,632,000
-7,523,000
-2,362,000
-2,137,000
-663,000
1,515,000
5,079,000
4,910,000
8,090,000
8,360,000
-22,105,000
138,754,000
131,047,000
130,025,000
156,357,000
-8,010,000
-7,311,000
-16,458,000
-10,560,000
-7,073,000
-4,632,000
3,916,000
733,000
-704,000
4,214,000
29,999,000
29,769,000
29,726,000
24,778,000
-159,000
106,000
47,000
-95,000
-3,688,000
-3,976,000
-4,207,000
-4,502,000
-3,010,000
-7,390,000
-17,489,000
-294,367,000
-327,699,000
-290,423,000
-279,814,000
-2,165,000
33,301,000
582,000
-439,000
-978,000
-201,000
-4,766,000
-1,644,000
4,986,000
7,915,000
17,123,000
63,137,000
61,002,000
40,952,000
167,418,000
121,082,000
134,217,000
152,039,000
23,131,000
22,076,000
6,595,000
35,595,000
34,088,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.